Health Trials

UDT1

1

Review clinical trials related to UDT1. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases

This study is a single-arm, multicenter, open-labeled clinical study of UTD1 combined with Capecitabine in metastatic HER2-negative breast cancaner patients with brain metastases. This study aims to evaluate the efficacy and safety of UDT1 combined with capecitabine in metastatic HER2-negative breast cancer patients with brain metastases.

Participants needed: 30
Trial details
Phase: Phase 1, Phase 2Age: 18-70Biological sex: FemaleType: InterventionalSponsor: Hunan Cancer HospitalUpdated: Apr 25, 2025Locations: 1
Eligibility criteria

Patients aged 18 to 70 years [+21]

Primary or metastatic lesions were HER2 positive (HER2 IHC or FISH positive) [+12]

Read more